Publications of Tanja M. Brückl

Breitenstein, B.; Scheuer, S.; Pfister, H.; Uhr, M.; Lucae, S.; Holsboer, F.; Ising, M.; Brückl, T. M.: The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study. CNS SPECTRUMS 19 (2), pp. 165 - 175 (2014)

Quast, C.; Cuboni, S.; Bader, D.; Altmann, A.; Weber, P.; Arloth, J.; Röh, S.; Brückl, T.; Ising, M.; Kopczak, A. et al.; Erhardt, A.; Hausch, F.; Lucae, S.; Binder, E. B.: Functional Coding Variants in SLC6A15, a Possible Risk Gene for Major Depression. PLOS ONE 8 (7), e68645 (2013)

Kloiber, S.; Ripke, S.; Kohli, M. A.; Reppermund, S.; Salyakina, D.; Uher, R.; McGuffin, P.; Perlis, R. H.; Hamilton, S. P.; Puetz, B. et al.; Hennings, J.; Brueckl, T.; Klengel, T.; Bettecken, T.; Ising, M.; Uhr, M.; Dose, T.; Unschuld, P. G.; Zihl, J.; Binder, E.; Mueller-Myhsok, B.; Holsboer, F.; Lucae, S.: Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels. EUROPEAN NEUROPSYCHOPHARMACOLOGY 23 (7), pp. 653 - 662 (2013)

Hennings, J. M.; Kohli, M. A.; Czamara, D.; Giese, M.; Eckert, A.; Wolf, C.; Heck, A.; Domschke, K.; Arolt, V.; Baune, B. T. et al.; Horstmann, S.; Brueckl, T.; Klengel, T.; Menke, A.; Mueller-Myhsok, B.; Ising, M.; Uhr, M.; Lucae, S.: Possible Associations of NTRK2 Polymorphisms with Antidepressant Treatment Outcome: Findings from an Extended Tag SNP Approach. PLOS ONE 8 (6), e64947 (2013)

Klengel, T.; Heck, A.; Pfister, H.; Brückl, T.; Hennings, J. M.; Menke, A.; Czamara, D.; Müller-Myhsok, B.; Ising, M.: Somatization in major depression - clinical features and genetic associations. Acta Psychiatrica Scandinavica 124 (4), pp. 317 - 328 (2011)

Hennings, J. M.; Kohli, M. A.; Czamara, D.; Wolf, C.; Domschke, K.; Arolt, V.; Baune, T.; Horstmann, S.; Brückl, T.; Klengel, T. et al.; Menke, A.; Müller-Myhsok, B.; Ising, M.; Uhr, M.; Lucae, S.: BDNF and NTRK2 polymorphisms and antidepressant treatment outcome. Pharmacopsychiatry 44 (6), p. 295 - 295 (2011)

Hoehne, N.; Rief, W.; Brückl, T.; Heck, A.; Pfister, H.; Lucae, S.; Uhr, M.; Holsboer, F.; Ising, M.: Stress coping strategies and HPA axis regulation predict relapse risk in remitted depression. European Neuropsychopharmacology 21 (Suppl. 3), p. S355 - S355 (2011)

Nocon, A.; Brückl, T.; Zimmermann, P.; Pfister, H.; Irving, H.; Rehm, J.; Lieb, R.; Wittchen, H. U.: The latent structure underlying the comorbidity of panic, agoraphobia and specific phobias. European Neuropsychopharmacology 21 (Suppl. 3), p. S533 - S533 (2011)

Szesny, N.; Brückl, T.; Pfister, H.; Hennings, J. M.; Klengel, T.; Menke, A.; Uhr, M.; Lucae, S.; Holsboer, F.; Ising, M. et al.; Zihl, J.: Effectiveness of a standardized cognitive training in depression and the interaction with HPA-axis regulation. Pharmacopsychiatry 44 (6), p. 308 - 308 (2011)

Hennings, J. M.; Kohli, M. A.; Czamara, D.; Heck, A.; Domschke, K.; Arolt, V.; Baune, B.; Horstmann, S.; Brueckl, T.; Klengel, T. et al.; Menke, A.; Müller-Myhsok, B.; Ising, M.; Uhr, M.; Holsboer, F.; Lucae, S.: BDNF and NTRK2 Polymorphisms and Antidepressant Treatment Response. Biological Psychiatry 69 (9 Suppl.1), p. 152 S - 152 S (2011)

Zimmermann, P.; Brückl, T.; Nocon, A.; Pfister, H.; Binder, E. B.; Uhr, M.; Lieb, R.; Moffitt, T. E.; Caspi, A.; Holsboer, F. et al.; Ising, M.: Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. American Journal of Psychiatry 168, pp. 1107 - 1116 (2011)

Hennings, J.; Kohli, M.; Heck, A.; Roeske, D.; Brückl, T.; Klengel, T.; Menke, A.; Müller-Myhsok, B.; Ising, M.; Holsboer, F. et al.; Lucae, S.: Polymorphisms in the BDNF gene are associated with antidepressant treatment response. European Neuropsychopharmacology 20 (Suppl. 3), pp. S427 - S428 (2010)

Kloiber, S.; Kohli, M. A.; Brueckl, T.; Ripke, S.; Ising, M.; Uhr, M.; Menke, A.; Unschuld, P. G.; Horstmann, S.; Salyakina, D. et al.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.; Lucae, S.: Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Molecular Psychiatry 15 (7), pp. 736 - 747 (2010)

Hennings, J. M.; Kohli, M. A.; Heck, A.; Roeske, D.; Horstmann, S.; Brückl, T.; Klengel, T.; Menke, A.; Müller-Myhsok, B.; Ising, M. et al.; Holsboer, F.; Lucae, S.: Polymorphisms in the BDNF Gene are Associated with Antidepressant Treatment Response. Biological Psychiatry 67 (9 Suppl.1), pp. 127S - 128S (2010)

Liu, J. Z.; Tozzi, F.; Waterworth, D. M.; Pillai, S. G.; Muglia, P.; Middleton, L.; Berrettini, W.; Knouff, C. W.; Yuan, X.; Waeber, G. et al.; Vollenweider, P.; Preisig, M.; Wareham, N. J.; Zhao, J. H.; Loos, R. J. F.; Barroso, I.; Khaw, K. T.; Grundy, S.; Barter, P.; Mahley, R.; Kesaniemi, A.; McPherson, R.; Vincent, J. B.; Strauss, J.; Kennedy, J. L.; Farmer, A.; McGuffin, P.; Day, R.; Matthews, K.; Bakke, P.; Gulsvik, A.; Lucae, S.; Ising, M.; Brueckl, T.; Horstmann, S.; Wichmann, H. E.; Rawal, R.; Dahmen, N.; Lamina, C.; Polasek, O.; Zgaga, L.; Huffman, J.; Campbell, S.; Kooner, J.; Chambers, J. C.; Burnett, M. S.; Devaney, J. M.; Pichard, A. D.; Kent, K. M.; Satler, L.; Lindsay, J. M.; Waksman, R.; Epstein, S.; Wilson, J. F.; Wild, S. H.; Campbell, H.; Vitart, V.; Reilly, M. P.; Li, M. Y.; Qu, L.; Wilensky, R.; Matthai, W.; Hakonarson, H. H.; Rader, D. J.; Franke, A.; Wittig, M.; Schäfer, A.; Uda, M.; Terracciano, A.; Xiao, X.; Busonero, F.; Scheet, P.; Schlessinger, D.; St Clair, D.; Rujescu, D.; Abecasis, G. R.; Grabe, H. J.; Teumer, A.; Volzke, H.; Petersmann, A.; John, U.; Rudan, I.; Hayward, C.; Wright, A. F.; Kolcic, I.; Wright, B. J.; Thompson, J. R.; Balmforth, A. J.; Hall, A. S.; Samani, N. J.; Anderson, C. A.; Ahmad, T.; Mathew, C. G.; Parkes, M.; Satsangi, J.; Caulfield, M.; Munroe, P. B.; Farrall, M.; Dominiczak, A.; Worthington, J.; Thomson, W.; Eyre, S.; Barton, A.; Mooser, V.; Francks, C.; Marchini, J.: Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics 42 (5), pp. 436 - 440 (2010)

Unschuld, P. G.; Ising, M.; Specht, M.; Erhardt, A.; Ripke, S.; Heck, A.; Kloiber, S.; Straub, V.; Brueckl, T.; Müller-Myhsok, B. et al.; Holsboer, F.; Binder, E. B.: Polymorphisms in the GAD2 Gene-Region Are Associated With Susceptibility for Unipolar Depression and With a Risk Factor for Anxiety Disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 150B (8), pp. 1100 - 1109 (2009)

Zimmermann, P.; Brückl, T.; Nocon, A.; Pfister, H.; Lieb, R.; Wittchen, H. U.; Holsboer, F.; Angst, J.: Heterogeneity of DSM-IV Major Depressive Disorder as a Consequence of Subthreshold Bipolarity. Archives of General Psychiatry 66 (12), pp. 1341 - 1352 (2009)

Brückl, T.; Lieb, R.; Pfister, H.; Wittchen, H. U.; Holsboer, F.; Ising, M.; Zimmermann, P.: Polymorphisms in the serotonin receptor 2A gene (HTR2A), parenting styles and the risk of depression in young adulthood: results from a family study. Pharmacopsychiatry 42 (5), p. 213 - 213 (2009)

Kloiber, S.; Kohli, M. A.; Brückl, T.; Ripke, S.; Ising, M.; Uhr, M.; Menke, A.; Unschuld, P. G.; Horstmann, S.; Salyakina, D. et al.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.; Lucae, S.: Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 42 (5), p. 226 - 226 (2009)

Zimmermann, P.; Brückl, T.; Pfister, H.; Lieb, R.; Wittchen, H. U.; Holsboer, F.; Ising, M.; Binder, E. B.; Uhr, M.; Nocon, A.: The interplay of variations in the FKBP5 gene and adverse life events in predicting the first onset of depression during a ten-year follow-up. Pharmacopsychiatry 42 (5), p. 249 - 249 (2009)